These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 560609

  • 1. Chronic phenylethylamine stereotypy in rats: a new animal model for schizophrenia?
    Borison RL, Havdala HS, Diamond BI.
    Life Sci; 1977 Jul 01; 21(1):117-22. PubMed ID: 560609
    [No Abstract] [Full Text] [Related]

  • 2. Neuroleptics attentuate stereotyped behavior induced by beta-phenylethylamine in rats.
    Moja EA, Stoff DM, Gillin JC, Wyatt RJ.
    Biol Psychiatry; 1978 Apr 01; 13(2):291-5. PubMed ID: 566570
    [No Abstract] [Full Text] [Related]

  • 3. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
    Stoff DM, Jeste DV, Gillin JC, Moja EA, Cohen L, Stauderman KA, Wyatt RJ.
    Biol Psychiatry; 1984 Jan 01; 19(1):101-6. PubMed ID: 6538440
    [No Abstract] [Full Text] [Related]

  • 4. Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia.
    Stoff DM, Moja EA, Gillin JC, Wyatt RJ.
    J Psychiatr Res; 1978 Jan 01; 14(1-4):225-40. PubMed ID: 281530
    [No Abstract] [Full Text] [Related]

  • 5. A new animal model for schizophrenia: cholinergic and serotonergic modulation.
    Borison RL, Havdala HS, Diamond BI.
    Commun Psychopharmacol; 1978 Jan 01; 2(3):209-14. PubMed ID: 308873
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A new putative neuroregulator of the extrapyramidal system.
    Diamond BI, Borison RL.
    Pharmacology; 1978 Jan 01; 17(4):210-4. PubMed ID: 29315
    [Abstract] [Full Text] [Related]

  • 8. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH, Smee ML, Woolston ME.
    Proc West Pharmacol Soc; 1976 Jan 01; 19():248-53. PubMed ID: 1033554
    [No Abstract] [Full Text] [Related]

  • 9. Phencyclidine-induced stereotyped behavior in rats: dose response effects and antagonism by neuroleptics.
    Murray TF, Horita A.
    Life Sci; 1979 Jun 11; 24(24):2217-25. PubMed ID: 41146
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats.
    Freemark M, Stoff DM, Moja EA, Gillin JC, Wyatt RJ.
    Biol Psychiatry; 1978 Aug 11; 13(4):455-63. PubMed ID: 28790
    [Abstract] [Full Text] [Related]

  • 12. Sex differences in stereotyped behavior in the rat.
    Beatty WW, Holzer GA.
    Pharmacol Biochem Behav; 1978 Dec 11; 9(6):777-83. PubMed ID: 570708
    [No Abstract] [Full Text] [Related]

  • 13. Dose-response effects of beta-phenylethylamine on stereotyped behavior in pargyline-pretreated rats.
    Moja EA, Stoff DM, Gillin JC, Wyatt RJ.
    Biol Psychiatry; 1976 Dec 11; 11(6):731-42. PubMed ID: 1033771
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phencyclidine-induced stereotyped behavior in monkeys: antagonism by pimozide.
    Schlemmer RF, Jackson JA, Preston KL, Bederka JP, Garver DL, Davis JM.
    Eur J Pharmacol; 1978 Dec 01; 52(3-4):379-84. PubMed ID: 103731
    [Abstract] [Full Text] [Related]

  • 16. Morphine induced stereotypic behavior in rat.
    Charness ME, Amit Z, Taylor M.
    Behav Biol; 1975 Jan 01; 13(1):71-80. PubMed ID: 1167447
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Amphetamine-induced locomotor activity and stereotypy after kainic acid lesions of the striatum.
    Mason ST, Sanberg PR, Fibiger HC.
    Life Sci; 1978 Feb 01; 22(6):451-9. PubMed ID: 24160
    [No Abstract] [Full Text] [Related]

  • 19. Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
    Timar J, Knoll B, Knoll J.
    Arch Int Pharmacodyn Ther; 1986 Dec 01; 284(2):255-66. PubMed ID: 3103558
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.